Study backs lower-cost CT pathway for acute thoracolumbar IVDE

Version 2 — Full analysis

A new Veterinary Surgery study is challenging the assumption that MRI should be the routine imaging choice before surgery in non-ambulatory chondrodystrophic dogs with acute thoracolumbar intervertebral disc extrusion. Investigators reported that conditional CT-myelography was non-inferior to MRI for recovery of ambulation, with no significant safety tradeoff and significantly lower imaging and total treatment costs. (onlinelibrary.wiley.com)

The question matters because MRI has long been treated as the anatomic gold standard for spinal cord imaging in dogs, especially when clinicians want more detail on intramedullary injury or need to rule out alternative diagnoses. But that higher level of detail comes with higher cost, longer scan times, and more limited availability. The 2022 ACVIM consensus statement already reflected that tension, concluding that MRI, CT, CT-myelography, and myelography are all reasonable for diagnosing acute thoracolumbar IVDE, and that CT can be recommended first-line in young to middle-aged chondrodystrophic dogs when mineralized extruded disc material is expected. (onlinelibrary.wiley.com)

In the new study, the authors used unscheduled MRI downtime as a quasi-randomizing event, creating a natural experiment rather than a conventional randomized trial. After exclusions, 560 non-ambulatory chondrodystrophic dogs underwent cross-sectional imaging in the intention-to-treat cohort, including 518 in the MRI group and 42 in the CT group; 522 dogs remained in the per-protocol analysis. Conditional CT-myelography was non-inferior to MRI for recovery of ambulation in both analyses, and there were no significant differences in postoperative neurologic deterioration, progressive myelomalacia, or major complications. The CT pathway also reduced total treatment costs, with the savings driven by imaging rather than downstream perioperative care. (onlinelibrary.wiley.com)

The study’s framing is notable because it moves beyond diagnostic sensitivity alone. Earlier evidence reviews have pointed out that MRI is more sensitive than non-contrast CT for detecting and characterizing thoracolumbar disc herniation, including lesion localization and distinguishing extrusion from protrusion. But those reviews also emphasize that test performance is only one part of the clinical decision. The newer paper asks a more practice-facing question: does routinely choosing MRI actually improve patient-centered outcomes in the dogs most likely to have classic acute TL-IVDE? In this cohort, the answer appeared to be no. (veterinaryevidence.org)

That said, the paper does not make MRI irrelevant. The ACVIM consensus states that MRI provides better definition of intramedullary lesions, can help with prognostication in paraplegic dogs, especially those that are deep-pain-negative, and has superior ability to identify diagnoses other than IVDE. The study authors make a similar point, noting that their findings are not definitive proof that MRI offers no benefit at all and suggesting that any advantage may be concentrated in a relatively small subset of patients, including deep-pain-negative dogs or dogs with a lower pretest probability of IVDE. (onlinelibrary.wiley.com)

That subgroup issue stands out because severe TL-IVDE cases still have relatively sparse interventional data. In a prospective randomized pilot study of 32 client-owned dogs with acute paraplegia and absent pain perception after thoracolumbar disc extrusion, all dogs underwent decompressive surgery within 24 hours and were assigned to subarachnoid saline, subarachnoid autologous platelet-rich plasma, or subarachnoid saline plus IV erythropoietin. At 3 months, 24 of 32 dogs (75%) regained ambulatory function, 7 did not, and 1 dog developed myelomalacia and was euthanized 4 days after surgery. There was no overall difference among treatment groups, although the erythropoietin group showed a possible trend toward reduced incontinence that the authors said would need confirmation in a larger study. In practical terms, that pilot adds to the sense that many adjunctive therapies in severe IVDE remain unproven, even when the underlying surgical pathway is standardized.

Perioperative supportive care is also getting tested more rigorously. In a prospective randomized, double-blind controlled trial of 30 dogs undergoing thoracolumbar hemilaminectomy for IVDE, intraoperative IV magnesium sulfate did not significantly improve postoperative pain scores or reduce IL-6 concentrations compared with saline placebo. Tumor necrosis factor-α was undetectable in most dogs, and the placebo group did not require significantly more rescue analgesia. Magnesium concentrations were transiently higher in treated dogs immediately and 1 hour after surgery, but not at 24 hours, and no adverse effects were reported. The one signal in magnesium’s favor was smoother anesthetic recovery, but the authors concluded there was no meaningful evidence to support its use specifically for postoperative analgesia or anti-inflammatory benefit in this setting.

Why it matters: For veterinary professionals, this study strengthens the case for matching imaging intensity to case selection rather than defaulting to the most information-rich modality. In referral and specialty settings where cost remains a barrier for many pet parents, a CT-first strategy in classic non-ambulatory chondrodystrophic IVDE cases could preserve access to surgery without compromising expected ambulatory outcomes. It also offers support for practices that already rely on CT, or CT with selective myelography, when MRI access is limited. Seen alongside the newer adjunctive-treatment trials, the broader message is that higher-cost or more complex additions to standard IVDE care do not automatically translate into better clinical outcomes. (onlinelibrary.wiley.com)

The bigger takeaway may be economic as much as clinical. The authors argue that when MRI produces similar aggregate outcomes at higher cost, routine use in this narrow population may represent low-value care. That won’t settle the modality debate for every neurologic patient, but it does add contemporary evidence to a long-running discussion about when MRI meaningfully changes management, and when it mainly adds expense. The same value lens is increasingly relevant for perioperative add-ons as well: erythropoietin, platelet-rich plasma, and magnesium sulfate each remain biologically interesting, but current clinical data do not show clear outcome-changing benefit for routine use in dogs undergoing surgery for TL-IVDE.

What to watch: Expect follow-up discussion around subgroup selection, especially whether future prospective work can identify which dogs truly benefit from MRI-first imaging, and whether these findings hold across institutions with different surgeon mix, imaging access, and triage patterns. Also watch for larger trials in deep-pain-negative dogs, where the pilot erythropoietin/platelet-rich plasma study hints at unresolved questions around continence and recovery, and for further work clarifying whether magnesium’s smoother recoveries have any practical relevance if analgesic and anti-inflammatory benefits remain absent. (onlinelibrary.wiley.com)